Article
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
Journal of clinical microbiology - 1 Oct 2002
Lok Anna S F, Zoulim Fabien, Locarnini Stephen, Mangia Alessandra, Niro Grazia, Decraemer Hilde, Maertens Geert, Hulstaert Frank, De Vreese Karen, Sablon Erwin
Abstract excerpt
Sensitive and early detection of emerging hepatitis B virus (HBV) drug resistance may not only help monitor the viral dynamics associated with lamivudine treatment but could also improve therapeutic decision making. This is especially important when new antivirals effective against lamivudine-res...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
